Skip to main content

Advertisement

SpringerLink
Log in

Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia

  • Original Article
  • Published:
Tumor Biology

Abstract

Aberrant microRNA (miRNA) expression participates in childhood acute lymphoblastic leukemia (ALL). This study aimed to investigate the expression of miRNA-100, miRNA-196a, and miRNA-146a among childhood ALL and study their correlation with other hematological parameters and different phenotypes. Peripheral blood mononuclear cells (PMNCs) were obtained from 85 childhood ALL and 25 healthy children for the detection of miRNA expression using quantitative real-time PCR. Significant higher median levels were reported for ALL compared to control children. The diagnostic efficacy for miRNA-146a was superior as both sensitivity and specificity were absolute. A significant correlation was observed between higher expression of miRNA-100 and lower platelet and lymphocyte counts; high expression of miRNA-146a showed significant correlation with low total leukocyte count (TLC) and lymphocyte counts. Significant relation was reported between studied miRNAs and different phenotyping. miRNA-100, miRNA-196a, and miRNA-146a have significant role in childhood ALL leukemogenesis, and they may be useful as biological diagnostic molecular markers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Crazzolara R, Bendall L. Emerging treatments in acute lymphoblastic leukemia. CurrCancer DrugTargets. 2009;9:19–31.

    CAS  Google Scholar 

  2. Ching-Hon P, Robison L, Thomas AL. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030–43.

    Article  Google Scholar 

  3. Pui CH. Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc. 2010;109:777–87.

    Article  PubMed  Google Scholar 

  4. Vitale A, Guarini A, Chiaretti S, Foa R. The changing scene of adult acute lymphoblastic leukemia. CurrOpinOncol. 2006;18:652–9.

    CAS  Google Scholar 

  5. Nguyen HT, Tian G, Murph MM. Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise? Frontiers in Oncology, doi: 10.3389/fonc.2014.00071 , 2014

  6. Swellam M, Abdelmaksoud MDE, Mahmoud MS, Ramadan A, Moneem WA, Hefny MM. Aberrant methylation of APC and RARb2 genes in breast cancer patients. IUBMB Life. 2015;67:61–8.

    Article  CAS  PubMed  Google Scholar 

  7. Fan Y, Fan J, Huang L, Ye M, Huang Z, Wang Y, et al. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma. Int J ClinExpPathol. 2015;8:4132–7.

    CAS  Google Scholar 

  8. Li Q, Liu L, Li W. Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis. Tumour Biol. 2014;35:10467–78.

    Article  CAS  PubMed  Google Scholar 

  9. Cui J. MiR-16 family as potential diagnostic biomarkers for cancer: a systematic review and meta-analysis. Int J ClinExp Med. 2015;8:1703–14.

    CAS  Google Scholar 

  10. Oorschot AAD, Kuipers JE, Arentsen-Peters S, Schotte D, De Haas V, Trka J, et al. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2012;58:715–21.

    Article  Google Scholar 

  11. Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A, et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia. 2010;24:89–96.

    Article  CAS  PubMed  Google Scholar 

  12. de Oliveira JC, Scrideli CA, Brassesco MS, Morales AG, Pezuk JA, QueirozRde P, et al. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. Leuk Res. 2012;36:293–8.

    Article  PubMed  Google Scholar 

  13. Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo XQ, Zeng CW, et al. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene. 2012;31:80–92.

    Article  PubMed  Google Scholar 

  14. Yu H, Lindsay J, Feng ZP, Frankenberg S, Hu Y,Carone D, Shaw G,Pask AJ, O’NeillR, Papenfuss AT, Renfree MB. Evolution of coding and non-coding genes in HOX clusters of a marsupial. BMC Genomics 2012, doi:10.1186/1471-2164-13-251

  15. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, et al. Baltimore DmiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med. 2011;208(6):1189–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay M. Role of miRNA-146a in the regulation of the innate immune response and cancer. BiochemSoc Trans. 2008;36:1211–5.

    Article  CAS  Google Scholar 

  17. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009;60:1065–75.

    Article  CAS  PubMed  Google Scholar 

  18. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561–77.

    CAS  PubMed  Google Scholar 

  19. Dong C, Ji M, Ji C. microRNAs and their potential target genes in leukemia pathogenesis. Cancer Biol Ther. 2009;8(3):200–5.

    Article  CAS  PubMed  Google Scholar 

  20. Wang Y, Li Z, He C, Wang D, Yuan X, Chen J, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cell Mol Dis. 2010;44:191–7.

    Article  CAS  Google Scholar 

  21. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, et al. Systematic comparison of microarray profiling, real-time PCR, and next generation sequencing technologies for measuring differential microRNA expression. RNA. 2010;16:991–1006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Schotte D, Lange-Turenhout EAM, Stumpel DJPM,Stam RW, JGCAM Buijs-GladdinesJGCAM, MeijerinkJPP, Pieters R,Boer MLD. “Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia,” Haematologica. 2010; 95:1675–1682. Stam RW, JGCAM Buijs-GladdinesJGCAM, MeijerinkJPP, Pieters R,Boer MLD

  23. Duyu M, Durmaz B, Gunduz C, Vergin C, KarapinarYD, Aksoylar S, Kavakli K, Cetingul N, Irken G, Yaman Y, Ozkinay F, Cogulu O. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia. BioMed Research International Volume 2014, Article ID 967585, 7 pages http://dx.doi.org/10.1155/2014/967585

  24. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103:12481–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Justiniano SE, Elavazhagan S, Fatehchand K, Shah P, Mehta P, Roda JM, et al. Fcγreceptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J Biol Chem. 2013;288:26800–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Coskun E, von der Heide EK, Schlee EC, Kuhnl A, Gokbuget N, Hoelzer D, et al. The role of miRNA-196a and miRNA 196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. Leukemia Res. 2011;35:208–13.

    Article  CAS  Google Scholar 

Download references

Acknowledgment

Authors contributed equally.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Genetic Engineering and Biotechnology Research Division, National Research Centre, Giza, 12622, Dokki, Egypt

    Menha Swellam

  2. Department of Clinical Pathology, Oncology Diagnostic Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Nashwa El-Khazragy

Authors
  1. Menha Swellam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nashwa El-Khazragy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Menha Swellam.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Swellam, M., El-Khazragy, N. Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia. Tumor Biol. 37, 10571–10576 (2016). https://doi.org/10.1007/s13277-016-4948-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-4948-7

Keywords

Search

Navigation